CircGFRA1 may function as a competing endogenous RNA (ceRNA) to regulate GFRA1 expression through sponging miR-34a to exert regulatory functions in triple negative breast cancer (TNBC). circGFRA1 may be a diagnostic biomarker and potential target for TNBC therapy.
circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a.